Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate.

Taylor DJ, Halpern V, Brache V, Bahamondes L, Jensen JT, Dorflinger LJ

Open source

DOI
10.1016/j.conx.2022.100073
Published
2022
Container
Contraception: X
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.conx.2022.100073,
  title = {Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate.},
  author = {Taylor DJ and Halpern V and Brache V and Bahamondes L and Jensen JT and Dorflinger LJ},
  year = {2022},
  journal = {Contraception: X},
  doi = {10.1016/j.conx.2022.100073},
  url = {https://doi.org/10.1016/j.conx.2022.100073}
}

RIS

TY  - JOUR
TI  - Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate.
AU  - Taylor DJ
AU  - Halpern V
AU  - Brache V
AU  - Bahamondes L
AU  - Jensen JT
AU  - Dorflinger LJ
PY  - 2022
JO  - Contraception: X
DO  - 10.1016/j.conx.2022.100073
UR  - https://doi.org/10.1016/j.conx.2022.100073
ER  - 

APA

DJ, T., V, H., V, B., L, B., JT, J., & LJ, D. (2022). Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate.. Contraception: X. https://doi.org/10.1016/j.conx.2022.100073

Source records